Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 350 participants.
Also called NCT05131139
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 350 participants
- Sponsor
- Registry
-
NCT05131139
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT05131139. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-10-20 (actual); primary completion 2025-03-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features
- Condition
- Diabetes Mellitus
- Condition
- Diabetes Mellitus, Type 1
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- Continuous Glucose Monitoring System
- Lead sponsor
- Senseonics, Inc.
Record details
- Record id
cardio:ct-nct05131139- Content hash
0315fec18485cd653751d3a80071c21ed91c3b7d387ed8890de6d706a83eb0a3